Kokichi Suzuki
Pharmaceutical Research Center
Meiji Seika Kaisha
LTD., Yokohama-shi
Kanagawa
Japan
Name/email consistency: high
- Enhancement of fibrinolysis by EF6265 [(S)-7-amino-2-[[[(R)-2-methyl-1-(3-phenylpropanoylamino)propyl]hydroxyphosphinoyl] methyl]heptanoic acid], a specific inhibitor of plasma carboxypeptidase B. Suzuki, K., Muto, Y., Fushihara, K., Kanemoto, K., Iida, H., Sato, E., Kikuchi, C., Matsushima, T., Kato, E., Nomoto, M., Yoshioka, S., Ishii, H. J. Pharmacol. Exp. Ther. (2004)
- Structural requirements for alkylglycoside-type renal targeting vector. Suzuki, K., Ando, T., Susaki, H., Mimori, K., Nakabayashi, S., Sugiyama, Y. Pharm. Res. (1999)
- Specific renal delivery of sugar-modified low-molecular-weight peptides. Suzuki, K., Susaki, H., Okuno, S., Yamada, H., Watanabe, H.K., Sugiyama, Y. J. Pharmacol. Exp. Ther. (1999)